 Karl Bayer
Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 62 | 2023 | 159 | 18.360 |
Why?
| | Long-Term Potentiation | 18 | 2023 | 148 | 5.880 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 22 | 2023 | 191 | 4.920 |
Why?
| | Long-Term Synaptic Depression | 9 | 2023 | 51 | 3.840 |
Why?
| | Synapses | 16 | 2023 | 344 | 3.570 |
Why?
| | Hippocampus | 27 | 2023 | 735 | 3.500 |
Why?
| | Calcium | 19 | 2023 | 1169 | 2.630 |
Why?
| | Phosphorylation | 35 | 2023 | 1633 | 2.610 |
Why?
| | Memory | 5 | 2023 | 230 | 2.180 |
Why?
| | Death-Associated Protein Kinases | 3 | 2021 | 10 | 2.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 13 | 2011 | 175 | 2.120 |
Why?
| | Glutamic Acid | 9 | 2023 | 224 | 2.060 |
Why?
| | Neurons | 21 | 2023 | 1345 | 2.050 |
Why?
| | Calmodulin | 9 | 2019 | 73 | 1.550 |
Why?
| | Heart Arrest | 3 | 2021 | 291 | 1.300 |
Why?
| | Neuronal Plasticity | 7 | 2023 | 219 | 1.250 |
Why?
| | Cell Death | 5 | 2021 | 339 | 1.110 |
Why?
| | Animals | 56 | 2023 | 33381 | 1.070 |
Why?
| | Ischemia | 3 | 2020 | 374 | 1.070 |
Why?
| | Rats | 31 | 2019 | 5392 | 1.020 |
Why?
| | Receptors, Metabotropic Glutamate | 2 | 2022 | 35 | 0.970 |
Why?
| | Brain Ischemia | 2 | 2021 | 310 | 0.940 |
Why?
| | Protein Binding | 16 | 2023 | 1975 | 0.930 |
Why?
| | Rats, Sprague-Dawley | 17 | 2020 | 2478 | 0.890 |
Why?
| | HEK293 Cells | 8 | 2020 | 625 | 0.860 |
Why?
| | Amino Acid Sequence | 14 | 2019 | 2071 | 0.860 |
Why?
| | Protein Processing, Post-Translational | 4 | 2019 | 408 | 0.830 |
Why?
| | CA1 Region, Hippocampal | 1 | 2021 | 30 | 0.790 |
Why?
| | Electrophysiological Phenomena | 1 | 2021 | 51 | 0.780 |
Why?
| | Protein Kinase Inhibitors | 8 | 2018 | 811 | 0.780 |
Why?
| | Alternative Splicing | 5 | 2006 | 193 | 0.770 |
Why?
| | Mice | 20 | 2023 | 15520 | 0.770 |
Why?
| | N-Methylaspartate | 9 | 2022 | 38 | 0.730 |
Why?
| | Holoenzymes | 2 | 2021 | 21 | 0.700 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2019 | 18 | 0.700 |
Why?
| | Mutation | 9 | 2020 | 3457 | 0.700 |
Why?
| | Brain | 7 | 2019 | 2490 | 0.680 |
Why?
| | Cerebral Cortex | 3 | 2021 | 416 | 0.680 |
Why?
| | Nitric Oxide | 2 | 2014 | 892 | 0.680 |
Why?
| | Post-Synaptic Density | 6 | 2016 | 11 | 0.660 |
Why?
| | Peptides | 6 | 2023 | 879 | 0.660 |
Why?
| | Lipoylation | 1 | 2017 | 16 | 0.630 |
Why?
| | Cells, Cultured | 13 | 2021 | 4077 | 0.620 |
Why?
| | Synaptic Transmission | 3 | 2019 | 239 | 0.610 |
Why?
| | Neuroprotective Agents | 3 | 2020 | 111 | 0.610 |
Why?
| | Protein Transport | 8 | 2019 | 412 | 0.600 |
Why?
| | Adenosine Diphosphate | 3 | 2015 | 88 | 0.600 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 72 | 0.590 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2871 | 0.590 |
Why?
| | Excitatory Amino Acid Agonists | 3 | 2014 | 39 | 0.580 |
Why?
| | Adenosine Triphosphate | 4 | 2013 | 439 | 0.560 |
Why?
| | Spine | 1 | 2017 | 144 | 0.560 |
Why?
| | Microscopy, Fluorescence | 3 | 2015 | 412 | 0.510 |
Why?
| | Second Messenger Systems | 1 | 2014 | 31 | 0.500 |
Why?
| | Models, Molecular | 8 | 2019 | 1435 | 0.490 |
Why?
| | Protein Conformation | 7 | 2021 | 848 | 0.470 |
Why?
| | Carrier Proteins | 6 | 2016 | 726 | 0.460 |
Why?
| | Membrane Proteins | 1 | 2019 | 1055 | 0.440 |
Why?
| | Protein Interaction Mapping | 2 | 2019 | 104 | 0.430 |
Why?
| | Actin Cytoskeleton | 3 | 2016 | 100 | 0.430 |
Why?
| | Protein Isoforms | 4 | 2018 | 345 | 0.420 |
Why?
| | Nucleotides | 1 | 2011 | 112 | 0.380 |
Why?
| | Drug Design | 1 | 2011 | 160 | 0.380 |
Why?
| | Actins | 4 | 2016 | 404 | 0.380 |
Why?
| | Green Fluorescent Proteins | 5 | 2015 | 395 | 0.380 |
Why?
| | Protein Domains | 4 | 2019 | 212 | 0.370 |
Why?
| | Transfection | 5 | 2017 | 888 | 0.370 |
Why?
| | Substrate Specificity | 4 | 2014 | 371 | 0.370 |
Why?
| | Nerve Tissue Proteins | 4 | 2019 | 551 | 0.370 |
Why?
| | Autophagy | 1 | 2014 | 315 | 0.370 |
Why?
| | Mice, Knockout | 3 | 2021 | 2680 | 0.340 |
Why?
| | Cell Line | 8 | 2011 | 2707 | 0.340 |
Why?
| | Isoenzymes | 5 | 2014 | 297 | 0.340 |
Why?
| | Peptide Fragments | 4 | 2018 | 702 | 0.340 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2018 | 290 | 0.340 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 4908 | 0.330 |
Why?
| | Neuroprotection | 2 | 2020 | 31 | 0.330 |
Why?
| | Benzylamines | 5 | 2013 | 40 | 0.290 |
Why?
| | Cell Nucleus | 3 | 2012 | 580 | 0.290 |
Why?
| | Amyloid beta-Peptides | 2 | 2019 | 200 | 0.280 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2016 | 105 | 0.250 |
Why?
| | Biological Products | 1 | 2007 | 170 | 0.250 |
Why?
| | Humans | 26 | 2020 | 118974 | 0.250 |
Why?
| | Ionomycin | 2 | 2019 | 24 | 0.250 |
Why?
| | Dendritic Spines | 3 | 2020 | 52 | 0.250 |
Why?
| | Enzyme Activation | 6 | 2017 | 828 | 0.240 |
Why?
| | Signal Transduction | 7 | 2014 | 4709 | 0.240 |
Why?
| | Binding Sites | 4 | 2014 | 1224 | 0.240 |
Why?
| | Protein Kinases | 1 | 2006 | 310 | 0.240 |
Why?
| | D-Aspartic Acid | 1 | 2023 | 2 | 0.230 |
Why?
| | Sulfonamides | 5 | 2013 | 445 | 0.230 |
Why?
| | Sarcoplasmic Reticulum | 2 | 2003 | 43 | 0.220 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2023 | 144 | 0.210 |
Why?
| | Optogenetics | 1 | 2023 | 96 | 0.210 |
Why?
| | Cell Hypoxia | 2 | 2015 | 220 | 0.210 |
Why?
| | Nucleus Accumbens | 2 | 2013 | 131 | 0.200 |
Why?
| | Protein Subunits | 2 | 2013 | 211 | 0.200 |
Why?
| | Male | 15 | 2021 | 57801 | 0.200 |
Why?
| | Embryo, Mammalian | 2 | 2015 | 220 | 0.190 |
Why?
| | Animals, Newborn | 3 | 2014 | 806 | 0.190 |
Why?
| | Swine | 1 | 2023 | 730 | 0.190 |
Why?
| | Single Molecule Imaging | 2 | 2021 | 35 | 0.190 |
Why?
| | Neural Inhibition | 2 | 2012 | 160 | 0.180 |
Why?
| | Neurotoxins | 1 | 2020 | 27 | 0.180 |
Why?
| | Female | 8 | 2021 | 61565 | 0.180 |
Why?
| | Point Mutation | 2 | 2014 | 228 | 0.180 |
Why?
| | Action Potentials | 2 | 2014 | 420 | 0.180 |
Why?
| | Enzyme Inhibitors | 6 | 2015 | 827 | 0.180 |
Why?
| | Protective Agents | 1 | 2019 | 42 | 0.180 |
Why?
| | Learning | 1 | 2023 | 374 | 0.170 |
Why?
| | Nervous System | 1 | 1999 | 66 | 0.170 |
Why?
| | Recombinant Fusion Proteins | 3 | 2010 | 653 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2006 | 814 | 0.170 |
Why?
| | Purkinje Cells | 1 | 2019 | 65 | 0.170 |
Why?
| | Spodoptera | 2 | 2009 | 37 | 0.170 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 823 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2014 | 300 | 0.170 |
Why?
| | Multigene Family | 1 | 2019 | 200 | 0.170 |
Why?
| | RNA, Messenger | 3 | 2018 | 2657 | 0.170 |
Why?
| | Mutagenesis | 2 | 2011 | 176 | 0.160 |
Why?
| | Movement | 1 | 2020 | 248 | 0.160 |
Why?
| | Resuscitation | 1 | 2020 | 253 | 0.150 |
Why?
| | Exons | 1 | 2018 | 307 | 0.150 |
Why?
| | Kinetics | 2 | 2011 | 1624 | 0.150 |
Why?
| | Receptors, AMPA | 2 | 2018 | 125 | 0.150 |
Why?
| | Membrane Potentials | 2 | 2014 | 253 | 0.140 |
Why?
| | Alzheimer Disease | 2 | 2019 | 513 | 0.140 |
Why?
| | Blotting, Western | 3 | 2009 | 1194 | 0.140 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 149 | 0.140 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 280 | 0.140 |
Why?
| | Proteins | 1 | 2001 | 938 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2013 | 1945 | 0.130 |
Why?
| | Pregnancy | 2 | 2018 | 5691 | 0.130 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 9 | 0.130 |
Why?
| | Ubiquitin-Specific Proteases | 1 | 2014 | 4 | 0.120 |
Why?
| | Electrical Synapses | 1 | 2014 | 4 | 0.120 |
Why?
| | COS Cells | 2 | 2006 | 184 | 0.120 |
Why?
| | Pepstatins | 1 | 2014 | 5 | 0.120 |
Why?
| | I-kappa B Kinase | 1 | 2014 | 50 | 0.120 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 38 | 0.120 |
Why?
| | Sequestosome-1 Protein | 1 | 2014 | 18 | 0.120 |
Why?
| | Phosphoserine | 1 | 2014 | 34 | 0.120 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 67 | 0.120 |
Why?
| | Muramidase | 1 | 2014 | 72 | 0.120 |
Why?
| | Staurosporine | 1 | 2013 | 23 | 0.120 |
Why?
| | RNA, Small Interfering | 2 | 2014 | 564 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2021 | 3730 | 0.120 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 29 | 0.120 |
Why?
| | RNA Interference | 2 | 2014 | 460 | 0.120 |
Why?
| | Genes, Reporter | 1 | 2014 | 270 | 0.120 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 160 | 0.120 |
Why?
| | Gap Junctions | 1 | 2014 | 58 | 0.120 |
Why?
| | GTPase-Activating Proteins | 1 | 2013 | 71 | 0.110 |
Why?
| | Leucine | 1 | 2014 | 117 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 129 | 0.110 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 43 | 0.110 |
Why?
| | Protease Inhibitors | 1 | 2014 | 102 | 0.110 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 148 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 403 | 0.110 |
Why?
| | Myosin Type I | 1 | 2012 | 1 | 0.110 |
Why?
| | Amphetamine-Related Disorders | 1 | 2013 | 28 | 0.110 |
Why?
| | Cytoplasmic Vesicles | 1 | 2012 | 12 | 0.110 |
Why?
| | Glucose Transporter Type 4 | 1 | 2012 | 38 | 0.110 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 188 | 0.110 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 136 | 0.110 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2011 | 2 | 0.100 |
Why?
| | Cognition | 1 | 2019 | 1024 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 289 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 940 | 0.100 |
Why?
| | Cocaine | 1 | 2013 | 158 | 0.100 |
Why?
| | Alanine | 1 | 2011 | 102 | 0.100 |
Why?
| | Solutions | 1 | 2011 | 156 | 0.100 |
Why?
| | Muscle, Skeletal | 2 | 2003 | 1515 | 0.100 |
Why?
| | Base Sequence | 3 | 2002 | 2159 | 0.100 |
Why?
| | Seizures | 1 | 2014 | 345 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2016 | 2025 | 0.100 |
Why?
| | Serine | 1 | 2011 | 138 | 0.100 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 20 | 0.090 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 18 | 0.090 |
Why?
| | PC12 Cells | 1 | 2010 | 40 | 0.090 |
Why?
| | Gene Products, tat | 1 | 2010 | 21 | 0.090 |
Why?
| | Insulin | 2 | 2012 | 2162 | 0.090 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 40 | 0.090 |
Why?
| | Conditioning, Classical | 1 | 2010 | 89 | 0.090 |
Why?
| | Patch-Clamp Techniques | 1 | 2010 | 247 | 0.090 |
Why?
| | Electric Stimulation | 1 | 2010 | 268 | 0.090 |
Why?
| | Rats, Wistar | 2 | 2007 | 399 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2013 | 1691 | 0.080 |
Why?
| | Cell Membrane | 1 | 2012 | 710 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1094 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 236 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 536 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2010 | 454 | 0.070 |
Why?
| | Behavior, Animal | 1 | 2010 | 486 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2006 | 3 | 0.070 |
Why?
| | Gene Expression | 2 | 2006 | 1489 | 0.070 |
Why?
| | 2-Amino-5-phosphonovalerate | 1 | 2006 | 11 | 0.070 |
Why?
| | Trinucleotide Repeats | 1 | 2006 | 24 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2006 | 100 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2006 | 84 | 0.070 |
Why?
| | Chickens | 1 | 2006 | 185 | 0.070 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2006 | 90 | 0.070 |
Why?
| | Glycine | 1 | 2006 | 162 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2006 | 276 | 0.060 |
Why?
| | Models, Biological | 3 | 2003 | 1715 | 0.060 |
Why?
| | Immunoblotting | 3 | 2013 | 307 | 0.060 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2014 | 17 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2003 | 46 | 0.060 |
Why?
| | Neurites | 1 | 2003 | 45 | 0.060 |
Why?
| | Integrins | 1 | 2003 | 82 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 298 | 0.050 |
Why?
| | Immunoprecipitation | 2 | 2014 | 161 | 0.050 |
Why?
| | Islets of Langerhans | 1 | 2007 | 739 | 0.050 |
Why?
| | Stroke | 1 | 2010 | 1047 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2002 | 546 | 0.050 |
Why?
| | Kidney | 2 | 2006 | 1353 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2001 | 181 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 2007 | 940 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1597 | 0.040 |
Why?
| | Ganglia | 1 | 1999 | 30 | 0.040 |
Why?
| | Enzyme Induction | 1 | 1999 | 94 | 0.040 |
Why?
| | Microsomes | 1 | 1998 | 24 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 1998 | 53 | 0.040 |
Why?
| | Organ Specificity | 1 | 1999 | 278 | 0.040 |
Why?
| | Head | 1 | 1999 | 89 | 0.040 |
Why?
| | Enzymes, Immobilized | 1 | 1998 | 31 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2018 | 55 | 0.040 |
Why?
| | Calcium Signaling | 1 | 2019 | 219 | 0.040 |
Why?
| | Biological Transport | 1 | 1998 | 382 | 0.040 |
Why?
| | Apoptosis | 1 | 2007 | 2484 | 0.040 |
Why?
| | Microscopy, Immunoelectron | 1 | 2016 | 45 | 0.040 |
Why?
| | Microscopy, Electron | 1 | 2017 | 413 | 0.040 |
Why?
| | Spinal Cord | 1 | 1999 | 367 | 0.040 |
Why?
| | Pseudopodia | 1 | 2016 | 20 | 0.040 |
Why?
| | Protein Multimerization | 1 | 2017 | 161 | 0.030 |
Why?
| | Microscopy, Confocal | 2 | 2010 | 314 | 0.030 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2017 | 183 | 0.030 |
Why?
| | Sarcomeres | 1 | 1996 | 91 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1996 | 268 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 533 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2014 | 21 | 0.030 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| | Polyubiquitin | 1 | 2014 | 7 | 0.030 |
Why?
| | Kainic Acid | 1 | 2014 | 32 | 0.030 |
Why?
| | Ion Transport | 1 | 2014 | 60 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 67 | 0.030 |
Why?
| | Muscle Proteins | 1 | 1996 | 219 | 0.030 |
Why?
| | Synaptic Membranes | 1 | 2013 | 18 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 139 | 0.030 |
Why?
| | Cell Fractionation | 2 | 2003 | 53 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2013 | 53 | 0.030 |
Why?
| | Polyribosomes | 1 | 2013 | 23 | 0.030 |
Why?
| | Calcium Channels, L-Type | 1 | 2014 | 110 | 0.030 |
Why?
| | Amphetamine | 1 | 2013 | 23 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2013 | 103 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1206 | 0.030 |
Why?
| | Rats, Long-Evans | 1 | 2013 | 105 | 0.030 |
Why?
| | Time Factors | 3 | 2013 | 6412 | 0.030 |
Why?
| | Potassium | 1 | 2013 | 132 | 0.030 |
Why?
| | Dendrites | 1 | 2013 | 88 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 292 | 0.030 |
Why?
| | Exocytosis | 1 | 2012 | 88 | 0.030 |
Why?
| | Lysine | 1 | 2014 | 248 | 0.030 |
Why?
| | Cytosol | 1 | 2012 | 221 | 0.030 |
Why?
| | Neural Pathways | 1 | 2013 | 277 | 0.030 |
Why?
| | Drug Interactions | 1 | 2013 | 352 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 217 | 0.030 |
Why?
| | Endocytosis | 1 | 2012 | 156 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 736 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 311 | 0.030 |
Why?
| | Central Nervous System Stimulants | 1 | 2013 | 142 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 369 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1996 | 1158 | 0.020 |
Why?
| | Liver | 1 | 1999 | 1816 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 872 | 0.020 |
Why?
| | Adrenergic alpha-1 Receptor Agonists | 1 | 2010 | 5 | 0.020 |
Why?
| | Phenylephrine | 1 | 2010 | 85 | 0.020 |
Why?
| | Calcineurin | 1 | 2010 | 95 | 0.020 |
Why?
| | Receptors, GABA-A | 1 | 2010 | 89 | 0.020 |
Why?
| | Thapsigargin | 1 | 2007 | 18 | 0.020 |
Why?
| | Androgen Receptor Antagonists | 1 | 2007 | 32 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 56 | 0.020 |
Why?
| | Luciferases | 1 | 2007 | 143 | 0.020 |
Why?
| | Androstadienes | 1 | 2007 | 94 | 0.020 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2007 | 114 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2010 | 709 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2007 | 156 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2007 | 134 | 0.020 |
Why?
| | Doxorubicin | 1 | 2007 | 302 | 0.020 |
Why?
| | Androgens | 1 | 2007 | 167 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2007 | 874 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 341 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2007 | 420 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 982 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 965 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2003 | 93 | 0.010 |
Why?
| | Isoquinolines | 1 | 2003 | 41 | 0.010 |
Why?
| | Organisms, Genetically Modified | 1 | 2003 | 18 | 0.010 |
Why?
| | Fibronectins | 1 | 2003 | 114 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2007 | 681 | 0.010 |
Why?
| | ras Proteins | 1 | 2003 | 141 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2010 | 2275 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 174 | 0.010 |
Why?
| | HeLa Cells | 1 | 2003 | 583 | 0.010 |
Why?
| | Cell Movement | 1 | 2003 | 896 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2003 | 759 | 0.010 |
Why?
|
|
Bayer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|